Cen Li

Title: The Innovative Contributions of Cen Li

Introduction

Cen Li is a notable inventor based in Qinghai, China. He has made significant strides in the field of pharmaceuticals, particularly in developing compositions that address cardiac toxicity induced by anthracyclines. His work is crucial for enhancing the safety and efficacy of cancer treatments.

Latest Patents

Cen Li holds a patent for the "Application of anthocyanin extract in preparing pharmaceutical composition for preventing and treating cardiac toxicity induced by anthracyclines." This patent outlines a pharmaceutical composition that includes an effective dose of anthocyanin extract, which is derived from mature fruits of a zygophyllaceous plant. The extract boasts a total anthocyanin content greater than 700 mg CGE/g and a total antioxidant capacity exceeding 200 mg TE/g. Research in cytobiology and molecular biology has demonstrated that this anthocyanin extract provides significant protection against cardiomyocyte toxicity caused by anthracyclines. This innovation not only expands the clinical applications of anthracyclines but also alleviates the toxic side effects experienced by chemotherapy patients.

Career Highlights

Cen Li is affiliated with the Chinese Academy of Sciences, where he conducts his research and development work. His contributions to the field of pharmaceuticals have been recognized for their potential to improve patient outcomes in cancer treatment.

Collaborations

Cen Li has collaborated with several colleagues, including Yuzhi Du and Tingting Gao, who have contributed to his research endeavors. Their teamwork has been instrumental in advancing the applications of his innovative discoveries.

Conclusion

Cen Li's work exemplifies the intersection of innovation and healthcare, particularly in the development of safer cancer treatments. His patent on anthocyanin extract showcases the potential for natural compounds to mitigate the adverse effects of chemotherapy. The advancements made by Cen Li and his collaborators are paving the way for improved therapeutic options for patients.